New York, New York-- (Newsfile Corp. - January 28, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...
Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of ...
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
TransMedics Gr TMDX has outperformed the market over the past 5 years by 12.34% on an annualized basis producing an average ...
TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and ...
JP Morgan has recently reduced TransMedics Group Inc (TMDX) stock to Neutral rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 22, 2024, Needham had reduced the ...
January 18, 2025, 05:16 am ET, BY Momei- Contributor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) ...
Zacks.com on MSN5d
TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall?TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.
Headwaters Capital Management highlighted stocks like TransMedics Group, Inc. (NASDAQ:TMDX) in the Q4 2024 investor letter. TransMedics Group, Inc. (NASDAQ:TMDX) is a commercial-stage medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback